Malin Life Sciences Holdings Ltd's Form 4 filing
Poseida Therapeutics, Inc. (PSTX) · filed Nov 23, 2021
- Accession no.
- 0001104659-21-143142
- Filed
- Nov 23, 2021
- Trade date
- Nov 19-23, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $181.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Malin Life Sciences Holdings LtdCIK 0001685138 | 10% Owner, Other: Common director with Issuer |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reported prices in Column 4 are weighted average prices. Those shares were purchased in multiple transactions at per share prices ranging from $7.37 to $7.54 on 11/19/2021; and $6.695 to $6.89 on 11/23/2021. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 2 transactions in Table I.